Kimberly A Kraynyak

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Circulating Tumor

Immune Response

Hepatitis C Virus

Top Venues

Cancer prevention research (Philadelphia, Pa.)

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Jeffrey M Jacobson, David M Zahrieh, Carrie A Strand, Marcia Roxana Cruz-Correa, Surakit Pungpapong, Lewis Rowland Roberts, Sumithra J Mandrekar, Luz Maria Rodriguez, Jean Boyer, Idania Marrero, Kimberly A Kraynyak, Matthew P Morrow, Albert J Sylvester, Jan M Pawlicki, Elisabeth Gillespie, Eduardo Barranco, Ellen Richmond, Asad Umar, David B Weiner, Paul J Limburg, null null
Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection. Cancer prevention research (Philadelphia, Pa.) 16 (3) (2023)
Jeffrey M Jacobson, David M Zahrieh, Carrie A Strand, Marcia Roxana Cruz-Correa, Surakit Pungpapong, Lewis Rowland Roberts, Sumithra J Mandrekar, Luz Maria Rodriguez, Jean Boyer, Idania Marrero, Kimberly A Kraynyak, Matthew P Morrow, Albert J Sylvester, Jan M Pawlicki, Elisabeth Gillespie, Eduardo Barranco, Ellen Richmond, Asad Umar, David B Weiner, Paul J Limburg, null null
Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection. Cancer prevention research (Philadelphia, Pa.) 16 (3) (2023)
Jeffrey M Jacobson, David M Zahrieh, Carrie A Strand, Marcia Roxana Cruz-Correa, Surakit Pungpapong, Lewis Rowland Roberts, Sumithra J Mandrekar, Luz Maria Rodriguez, Jean Boyer, Idania Marrero, Kimberly A Kraynyak, Matthew P Morrow, Albert J Sylvester, Jan M Pawlicki, Elisabeth Gillespie, Eduardo Barranco, Ellen Richmond, Asad Umar, David B Weiner, Paul J Limburg, null null
Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection. Cancer prevention research (Philadelphia, Pa.) 16 (3) (2023)
Jeffrey M Jacobson, David M Zahrieh, Carrie A Strand, Marcia Roxana Cruz-Correa, Surakit Pungpapong, Lewis Rowland Roberts, Sumithra J Mandrekar, Luz Maria Rodriguez, Jean Boyer, Idania Marrero, Kimberly A Kraynyak, Matthew P Morrow, Albert J Sylvester, Jan M Pawlicki, Elisabeth Gillespie, Eduardo Barranco, Ellen Richmond, Asad Umar, David B Weiner, Paul J Limburg, null null
Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection. Cancer prevention research (Philadelphia, Pa.) 16 (3) (2023)
Jeffrey M Jacobson, David M Zahrieh, Carrie A Strand, Marcia Roxana Cruz-Correa, Surakit Pungpapong, Lewis Rowland Roberts, Sumithra J Mandrekar, Luz Maria Rodriguez, Jean Boyer, Idania Marrero, Kimberly A Kraynyak, Matthew P Morrow, Albert J Sylvester, Jan M Pawlicki, Elisabeth Gillespie, Eduardo Barranco, Ellen Richmond, Asad Umar, David B Weiner, Paul J Limburg, null null
Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection. Cancer prevention research (Philadelphia, Pa.) (2022)
Robert H Vonderheide, Kimberly A Kraynyak, Anthony F Shields, Autumn J McRee, Jennifer M Johnson, Weijing Sun, Ashish V Chintakuntlawar, Jan Pawlicki, Albert J Sylvester, Trevor McMullan, Robert Samuels, Joseph J Kim, David Weiner, Jean D Boyer, Matthew P Morrow, Laurent Humeau, Jeffrey M Skolnik
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors. Journal for immunotherapy of cancer 9 (7) (2022)
Jeffrey M Jacobson, David M Zahrieh, Carrie A Strand, Marcia Roxana Cruz-Correa, Surakit Pungpapong, Lewis Rowland Roberts, Sumithra J Mandrekar, Luz Maria Rodriguez, Jean Boyer, Idania Marrero, Kimberly A Kraynyak, Matthew P Morrow, Albert J Sylvester, Jan M Pawlicki, Elisabeth Gillespie, Eduardo Barranco, Ellen Richmond, Asad Umar, David B Weiner, Paul J Limburg
Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection. Cancer prevention research (Philadelphia, Pa.) (2022)